Federated Hermes, Inc. Sanofi Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Sanofi stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,326,038 shares of SNY stock, worth $163 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,326,038

Previous 3,214,141 3.48%

Holding current value

$163 Million

Previous $156 Million 22.97%

% of portfolio

0.44%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$48.54 - $58.53 $5.43 Million - $6.55 Million	111,897 Added 3.48%	3,326,038 $192 Million
Q2 2024 Aug 08, 2024	BUY	$45.39 - $50.36 $30.6 Million - $33.9 Million	673,172 Added 26.49%	3,214,141 $156 Million
Q1 2024 May 14, 2024	BUY	$45.75 - $52.48 $37.7 Million - $43.2 Million	823,649 Added 47.96%	2,540,969 $123 Million
Q4 2023 Jan 31, 2024	SELL	$43.13 - $54.79 $32.6 Million - $41.4 Million	-755,840 Reduced 30.56%	1,717,320 $85.4 Million
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $4.86 Million - $5.27 Million	-95,408 Reduced 3.71%	2,473,160 $133 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $23.6 Million - $26.7 Million	466,819 Added 22.21%	2,568,568 $138 Million
Q1 2023 May 08, 2023	BUY	$45.86 - $54.45 $85.1 Million - $101 Million	1,856,263 Added 756.16%	2,101,749 $114 Million
Q4 2022 Feb 13, 2023	SELL	$38.86 - $48.55 $3.94 Million - $4.92 Million	-101,412 Reduced 29.23%	245,486 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $1.98 Million - $5.34 Million	-53,101 Reduced 13.28%	346,898 $13.2 Million
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $4.95 Million - $5.8 Million	100,988 Added 33.77%	399,999 $20 Million
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $4.02 Million - $4.45 Million	82,936 Added 38.38%	299,011 $15.4 Million
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $682,515 - $759,075	-14,500 Reduced 6.29%	216,075 $10.8 Million
Q3 2021 Nov 15, 2021	SELL	$47.89 - $53.12 $468,938 - $520,151	-9,792 Reduced 4.07%	230,575 $11.1 Million
Q2 2021 Aug 16, 2021	BUY	$49.36 - $54.25 $925,105 - $1.02 Million	18,742 Added 8.46%	240,367 $12.7 Million
Q1 2021 May 13, 2021	BUY	$45.46 - $50.51 $23,411 - $26,012	515 Added 0.23%	221,625 $11 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $51.62 $473,294 - $539,325	-10,448 Reduced 4.51%	221,110 $10.7 Million
Q3 2020 Nov 12, 2020	BUY	$49.47 - $53.77 $534,572 - $581,038	10,806 Added 4.9%	231,558 $11.6 Million
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $4.18 Million - $5.11 Million	-97,403 Reduced 30.61%	220,752 $11.3 Million
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $200,327 - $272,196	5,269 Added 1.68%	318,155 $13.9 Million
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $72,835 - $83,715	1,646 Added 0.53%	312,886 $15.7 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $338,371 - $391,216	-8,388 Reduced 2.62%	311,240 $14.4 Million
Q2 2019 Aug 14, 2019	BUY	$40.43 - $44.3 $49,688 - $54,444	1,229 Added 0.39%	319,628 $13.8 Million
Q1 2019 May 10, 2019	SELL	$40.83 - $45.43 $7.9 Million - $8.79 Million	-193,467 Reduced 37.8%	318,399 $14.1 Million
Q4 2018 Feb 13, 2019	BUY	$41.48 - $45.59 $8.05 Million - $8.85 Million	194,102 Added 61.08%	511,866 $22.2 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $71.4 Million - $80.1 Million	-1,786,196 Reduced 84.9%	317,764 $14.2 Million
Q2 2018 Aug 10, 2018	SELL	$37.63 - $41.22 $5.59 Million - $6.12 Million	-148,576 Reduced 6.6%	2,103,960 $84.2 Million
Q1 2018 May 09, 2018	SELL	$38.98 - $45.76 $7.13 Million - $8.37 Million	-182,844 Reduced 7.51%	2,252,536 $90.3 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $39.8 Million - $47 Million	-929,123 Reduced 27.62%	2,435,380 $0
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $158 Million - $169 Million	3,364,503	3,364,503 $168 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Sanofi Transaction History